A phase 1/2 and biomarker study of preoperative short course chemoradiation with proton beam therapy and capecitabine followed by early surgery for resectable pancreatic ductal adenocarcinoma.
一项针对可切除胰腺导管腺癌的术前短期放化疗(质子束疗法和卡培他滨)后早期手术的 1/2 期生物标志物研究
期刊:International Journal of Radiation Oncology Biology Physics
影响因子:6.5
doi:10.1016/j.ijrobp.2014.03.034
Hong Theodore S, Ryan David P, Borger Darrell R, Blaszkowsky Lawrence S, Yeap Beow Y, Ancukiewicz Marek, Deshpande Vikram, Shinagare Shweta, Wo Jennifer Y, Boucher Yves, Wadlow Raymond C, Kwak Eunice L, Allen Jill N, Clark Jeffrey W, Zhu Andrew X, Ferrone Cristina R, Mamon Harvey J, Adams Judith, Winrich Barbara, Grillo Tarin, Jain Rakesh K, DeLaney Thomas F, Fernandez-del Castillo Carlos, Duda Dan G